Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Menu
Search
Subscribe
Home
Contact Us
Subscription Services
Promote Your Event
e-Edition
News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Place an Ad
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Athersys, Inc.
< Previous
1
2
Next >
Patient Enrollment Begins in Third and Final Cohort of the Phase 2 MATRICS-1 Clinical Study Evaluating Athersys’ MultiStem® Following Hemorrhagic Trauma
June 01, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Restructures Debt with Supplier
May 23, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Reports First Quarter 2023 Financial Results and Business Highlights
May 18, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Participate in Three Upcoming Conferences
May 08, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Participate in The Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Conference
May 01, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Participate in The American Society for Neural Therapy and Repair Annual Conference
April 21, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys, Inc. Announces Closing of $3.7 Million Registered Direct Offering and Concurrent Private Placement
April 19, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys, Inc. Announces $3.7 Million Registered Direct Offering and Concurrent Private Placement
April 18, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Host Business Update Conference Call on April 20th
April 10, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
March 31, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Announces Successful Type B Meeting with the FDA
March 22, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Expands IP Protection with First New Patent for SIFU® Technology
February 28, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Granted Clinical Type B Meeting with FDA for MASTERS-2 Clinical Trial Protocol Discussion
February 14, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Host Business Update Conference Call on February 14th
February 02, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Participate in International Stroke Conference and BioProcess International
January 30, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Participate in Advanced Therapies Week and Allogeneic Cell Therapies Summit Europe in January
January 11, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Provides MultiStem Clinical Update
January 09, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Appoints Joseph Nolan to Its Board of Directors
January 05, 2023
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Reports Third Quarter 2022 Financial Results and Provides Business Update
November 15, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Present at Challenges and Opportunities for Mesenchymal Stem Cells Digital Conference and Participate in A.G.P.’s Biotech Conference
November 11, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys, Inc. Announces Closing of $5.5 Million Confidentially Marketed Public Offering
November 10, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Reschedules Third Quarter Conference Call to November 15
November 10, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys, Inc. Announces Pricing of $5.5 Million Public Offering
November 09, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys, Inc. Announces Proposed Public Offering
November 07, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Host Third Quarter Financial Results Call
October 25, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Present at 2022 Cell & Gene Meeting on the Mesa Conference and Attend 14th World Stroke Congress in October
October 04, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys to Host Business Update Conference Call on October 6th
September 30, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Amends Securities Purchase Agreement in Connection with Recent Registered Direct Offering
September 23, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys Announces 1-for-25 Reverse Stock Split
August 25, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
Athersys, Inc. Announces Closing of $12 Million Registered Direct Offering
August 17, 2022
From
Athersys, Inc.
Via
Business Wire
Tickers
ATHX
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.